R. Asinger

Publications138
h-index46
Citations12,899
Highly Influential Citations229
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • R. Hart
  • 401 Publications, 40,534 Citations
  • L. Pearce
  • 147 Publications, 16,613 Citations
  • J. Halperin
  • 556 Publications, 96,091 Citations
  • S. Hohnloser
  • 699 Publications, 53,895 Citations
  • Publications
  • Influence
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice…
Atrial fibrillation (AF), the most common sustained cardiac rhythm disturbance, is increasing in prevalence as the population ages. Although it is often associated with heart disease, AF occurs in… Expand
  • 1,549
  • 48
  • PDF
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
Cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD) is high, and the presence of CKD worsens outcomes of cardiovascular disease (CVD). CKD is associated with specific… Expand
  • 618
  • 26
  • PDF
ST-segment elevation in conditions other than acute myocardial infarction.
Many conditions other than acute myocardial infarction cause elevation of ST segments on an electrocardiogram. This review explains the conditions that may mimic acute myocardial infarction… Expand
  • 532
  • 25
  • PDF
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators.
OBJECTIVE This study was performed to characterize the risk of stroke in elderly patients with recurrent intermittent atrial fibrillation (AF). BACKGROUND Although intermittent AF is common,… Expand
  • 628
  • 20
  • PDF
Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.
BACKGROUND The conventional treatment strategy for patients with atrial fibrillation who are to undergo electrical cardioversion is to prescribe warfarin for anticoagulation for three weeks before… Expand
  • 642
  • 16
Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators.
OBJECTIVES This study explored the mechanisms linking clinical and precordial echocardiographic predictors to thromboembolism in atrial fibrillation (AF) by assessing transesophageal… Expand
  • 474
  • 11
  • PDF
Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation…
BACKGROUND AND PURPOSE Nonvalvular atrial fibrillation (AF) is a strong, independent risk factor for stroke, but the absolute rate of stroke varies widely among AF patients, importantly influencing… Expand
  • 527
  • 10
  • PDF
Warfarin in atrial fibrillation patients with moderate chronic kidney disease.
BACKGROUND AND OBJECTIVES The efficacy of adjusted-dose warfarin for prevention of stroke in atrial fibrillation patients with stage 3 chronic kidney disease (CKD) is unknown. DESIGN, SETTING,… Expand
  • 171
  • 9
  • PDF
Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography.
To study the incidence of left-ventricular thrombosis after transmural myocardial infarction, we performed serial two-dimensional echocardiography in 70 consecutive patients. Thirty-five patients had… Expand
  • 520
  • 7
Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial.
CONTEXT The effectiveness of recruiting local medical opinion leaders to improve quality of care is poorly understood. OBJECTIVE To evaluate a guideline-implementation intervention of clinician… Expand
  • 349
  • 4
  • PDF